Parathyroid hormone plasma concentrations in response to low 25-OH vitamin D circulating levels increases with age in elderly women. by Reginster, Jean-Yves et al.
Letter
Parathyroid hormone plasma concentrations in
response to low 25-OH vitamin D circulating levels
increases with age in elderly women
Sir—Several reports have concluded that low 25-OH vitamin
D (25-OH D) circulating levels are a common feature in
elderly women who are either community-dwelling or living in
nursing homes [1–3]. Impaired vitamin D metabolism and
subsequent increase in parathyroid hormone (PTH) secretion
are considered significant determinants of age-related osteo-
porosis [1,4]. High PTH levels in the elderly are associated
with low vertebral bone density [5], decrease cortical thickness
[6], increase in bone turnover rate [1,7] and increased risk of
hip fracture [8]. Supplementation of elderly subjects with
vitamin D and calcium was shown to significantly reduce non-
vertebral fractures [9] but only if serum PTH is concomitantly
decreased [10]. We previously reported that 25-OH D levels
were reduced to a similar extent, after adjustment for age, in
elderly women who were community-dwellers or nursing
home residents [11]. However, we also showed that in very old
women (over 80 years old), non-significant differences in
vitamin D levels between nursing home residents and
community-dwellers could translate into a significant differ-
ence in PTH. In the present paper, we investigate whether or
not the response of PTH secretion to a decrease in circulating
levels of vitamin D is influenced by the age of the subjects. For
the present trial, we used the values of 25-OH D and PTH
circulating levels obtained from a previously described
epidemiological survey [11,12]. Briefly, general practitioners
trained for participating in osteoporosis clinical trials recruited
from their practice women aged 70 years and over, either
community-dwelling or living in nursing homes. In this
survey, 1483 women consented to participate and we obtained
serum samples from 748 (50.4%) subjects. Serum 25-OH D
and PTH were assessed by commercially marketed radio-
immunoassay kits (Incstar, Stillwater, MN). In our experience,
the intra- and inter-assay coefficients of variation are
respectively 8% and less than 12% for 25-OH D and 6% and
less than 10% for PTH. Daily calcium intake was evaluated, on
the day on which blood was drawn, by a previously validated
and published self-administered questionnaire [13].
Results were expressed as mean + SEM. To compare the
daily calcium intake in the community-dwellers and nursing
home groups, a Student’s t-test was applied. Log transforms
were used for vitamin D and PTH to normalize their
distribution. To assess the (linear) relation between two
continuous variables, the Pearson correlation coefficient was
calculated. A multiple regression was applied to study PTH
secretion. The effects of group, age and vitamin D were tested.
All results were considered to be significant at the 5% level
(p50.05). Statistical calculations were carried out using the
SAS software package (SAS Institute Cary, NC).
Daily calcium intake was not significantly different in
community-dwellers (612 + 34 mg/day) (mean + SEM) and
nursing home residents (606 mg/day). No significant relation
was shown between age and daily calcium intake in the whole
population (p = 0.88), in community-dwellers (p = 0.74) or in
nursing home residents (p = 0.82). The mean values (SEM) of
25-OH D and PTH were respectively 12.2 (0.1) ng/ml and 34.1
(1.0) pg/ml in our population of elderly women. Age was
correlated negatively with 25-OH D (r = 70.22, p50.001)
and positively with PTH (r = 0.16, p50.001). PTH was
inversely correlated with 25-OH D (r = 70.26; p50.001).
After adjustment for type of living (community-dwelling or
nursing home residence), it appeared that age remained a
significant determinant (p50.001) of the relation between 25-
OH D and PTH (Fig. 1). Applied to our population of elderly
women, this age-dependent effect corresponds to a difference
of more than 20% in PTH levels for similar 25-OH D values,
between the age of 70 and 95 years (Table 1).
The levels of 25-OH D measured in the present study are
slightly lower than those reported recently in a population of
elderly European women (born between 1913 and 1918), even
for those living at the same latitude (50–558 N) as our city [3].
However, they are compatible with those found in French
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Table 1. Mean PTH values, for 25-OH D levels at 12, 18, 25, 30 and 45 ng/ml, in women between 70 and 95 years old
Vitamin D PTH (pg/ml)
(ng/ml)
70 years 75 years 80 years 85 years 90 years 95 years
12 24.5 25.6 26.8 28.0 29.3 30.7
18 22.3 23.4 24.4 25.6 26.8 28.0
25 20.7 21.7 22.7 23.7 24.8 26.0
30 19.9 20.8 21.8 22.8 23.8 24.9
45 18.1 19.0 19.9 20.8 21.7 22.7
women, both at home or institutionalized [1,14]. A progressive
decrease in 25-OH D and an increase in PTH with age was
previously documented [15,16]. The interesting feature of our
results is the increased levels in PTH with aging, for similar
values of 25-OH D. Serum calcium was not measured in the
survey. One cannot thus completely exclude the possibility of
increased PTH secretion as a consequence of a decrease in
serum calcium with age. Daily calcium intake was not age-
related in our population and thus cannot account for our
results. Alteration in 1,25-(OH)2 vitamin D production is
known to be a feature of the process of aging. Secondary
hyperparathyroidism in the elderly was also related to
progressive renal insufficiency [18], even though some authors
consider that a decrease in renal function is not the major
factor accounting for the rise in serum PTH with age [16]. In
our study, severe renal insufficiency was an exclusion
criterion. Intestinal resistance to the action of 1,25-(OH)2 D
would be another potential explanation. Decreasing growth
hormone and insulin-like growth factor I concentrations were
also suggested to play a possible role in the mineral
homeostasis of the elderly [15]. We did not measure these
parameters in our study. Whatever the mechanism underlying
this increase in PTH levels in response to low 25-OH D in the
elderly, the major consequence is that the level of 25-OH D
deficiency leading in relevant hyperparathyroidism in the
elderly is likely to be much lower than currently defined. 25-
OH D levels of 30 ng/ml in a 90-year-old woman are
associated with mean PTH levels higher than those observed
with 25-OH D at 12 ng/ml at the age of 75 years. We [11] and
others [1,3] have already mentioned the underestimation of the
high prevalence of vitamin D deficiency in elderly European
women. Our present results stress the importance of adequate
vitamin D repletion, particularly in elderly women, to avoid
secondary hyperparathyroidism.
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